sirolimus
美 
英
例句
However, sirolimus stents fared better than paclitaxel stents in terms of MI, target vessel revascularization, and late thrombosis.
在心梗、靶血管的血運重建和晚期血栓文面，西羅莫司支架優于紫杉醇支架。
Stent thrombosis after 1 year was more common with both sirolimus-eluting stents and paclitaxel-eluting stents than with bare-metal stents.
與裸金屬支架組相比，1年后雷帕霉素和紫杉醇藥物涂層支架組更容易發生血栓。
Drug discontinuation due to an adverse event was also more frequent in the sirolimus cohort compared to those patients continued on CNI.
在西羅莫司組中因不良事件而導致停藥的也多于繼續使用CNI治療的患者。
Therapeutic drug monitoring should not be the sole basis for adjusting sirolimus therapy.
治療藥物監測不應作為調整西羅莫司治療的唯一根據。
Kushwaha and colleagues tested the use of sirolimus as an alternative anti-proliferative immunosuppressant drug.
Kushwaha和他的同事試驗西羅莫司作為可選擇的抗增值免疫抑制藥物的使用。
A novel, simple and cost effective assay for monitoring blood levels of rapamycin (sirolimus) and rapamycin analogues was developed.
我們開發了一項用于檢測血液中雷帕霉素（西羅莫司）和雷帕霉素類似物濃度的簡便、經濟節省的新型分析方法。
Sirolimus is indicated for the prophylaxis of organ rejection in patients aged 13 years or older receiving kidney transplants.
西羅莫司用于在13歲及以上接受腎移植患者中預防器官排斥反應。
At this time, FDA has not made any changes to the professional label for sirolimus.
目前，FDA尚未對西羅莫司的專業標簽信息做出任何修改。
Sirolimus monotherapy may be safe, but experience is limited and side effects such as hyperlipidemia must be monitored.
西羅莫斯單一治療可能安全，但是治療經驗有限并且需要監測高脂血癥的副作用。
In all 4 patients, sirolimus-induced pneumonitis resolved following cessation of therapy but took weeks to months for complete recovery.
全部4名患者的西羅莫司誘導性肺炎都在治療結束得到消散，但數周至數月后才完全康復。
Beyond 2 years, the increase in plaque volume, but not plaque index, was significantly lower with sirolimus than calcineurin inhibitors.
超過兩年，使用西羅莫林的患者比使用神經鈣蛋白抑制因子的患者在斑塊體積而不是斑塊指數上的增大很大程度上要小的多。
Objective To observe the effect of application of Sirolimus on adventitia in preventing stenosis of vein graft.
目的探討血管外膜應用西羅莫司對靜脈移植物再狹窄的作用。
Sirolimus is a kind of macrolide antibiotics as well as immunosuppressant.
西羅莫司是一種大環內酯類抗生素，為一種免疫抑制劑。
The FDA is determining whether a labeling change for sirolimus is needed.
FDA正在醞釀是否需要修改西羅莫司的標簽信息。
The effect of sirolimus, a new immunosuppressant, on vaccine responses has been little studied.
西羅莫司（一種新的免疫抑制劑）對于接種疫苗應答影響的研究尚少。
Immunosuppression included de noo sirolimus, low-dose calcineurin inhibitor for 6 to 12 months, with short-course (3 months) or no steroids.
免疫抑制方案包括術后起始即用西羅莫司、低劑量鈣調蛋白抑制劑使用6-12個月，聯用短程（3個月）或者不使用激素。
The synergic effects of sirolimus and immature dendritic cells in prolonging survival time of skin allograft in mice
西羅莫司與未成熟樹突狀細胞延長小鼠皮膚移植存活時間的協同作用
Determination of the plasma sirolimus concentrations in patients after renal transplantation by HPLC method
HPLC法檢測腎移植病人全血中西羅莫司的藥物濃度
Study of sirolimus-eluting stent in treatment of elderly pretty long coronary artery lesions
雷帕霉素洗脫支架治療老年冠狀動脈特長病變的臨床研究
Sirolimus inhibits the differentiation, proliferation and migration of endothelial progenitor cells in vitro
雷帕霉素對內皮祖細胞增殖、黏附及遷移能力影響的實驗研究
Analysis of acute and subacute stent thrombosis after successful implantation of sirolimus-eluting stent in complex coronary lesions
復雜冠狀動脈病變西羅莫司洗脫支架置入后急性和亞急性支架內血栓形成情況分析
Comparison of the application of sirolimus eluting stents and paclitaxel eluting stents in coronary lesions
西羅莫司和紫杉醇藥物洗脫支架治療冠狀動脈疾病的對比研究
Nine cases of conversion from calcineurin inhibitor to sirolimus in the treatment of urological neoplasm in kidney allograft recipients
腎移植后泌尿系統腫瘤患者應用西羅莫司替代鈣調磷酸酶抑制劑九例
Clinical observation on sirolimus- eluting stent implantation in left main coronary artery bifurcation lesions
左主干末端病變選擇性雷帕霉素洗脫支架術臨床評價
One-year clinical outcomes of domestic sirolimus-eluting stent in treating unselected patients with coronary artery disease
國產與進口西羅莫司藥物洗脫支架治療冠心病臨床療效對比
The clinical efficacy of sirolimus-eluting stents versus paclitaxel-eluting stents in complex and diffuse coronary lesions
兩種藥物洗脫支架在冠狀動脈復雜彌漫病變中的療效比較
Clinical and angiographic follow-up observation of sirolimus-eluting stents in the treatment of complex coronary lesions
雷帕霉素洗脫支架治療冠狀動脈長病變的隨訪觀察
Short-term clinical observation of low-dose sirolimus in living relative kidney transplantation from elderly donor
接受老齡親屬活體供腎移植者采用小劑量西羅莫司的近期臨床觀察
Evaluation of clinical outcomes of sirolimus-eluting stents treated to coronary bifurcation lesions
雷帕霉素洗脫支架治療冠狀動脈分叉病變的臨床療效評價
The impact of expansion of sirolimus eluting stent on intimal hyperplasia: an intravascular ultrasound study
雷帕霉素洗脫支架擴張程度對內膜增生影響的血管內超聲研究
Sirolimus-eluting stents with modified T-stenting technique for reverse crushing on bifurcation lesions
改良T型藥物洗脫支架置入術治療冠狀動脈分叉病變
Determination of peroxide value in sirolimus oral solution by potentiometric-iodometry
碘量法電位滴定西羅莫司口服溶液劑的過氧化值
The Efficacy of Sirolimus-eluting Stents and Bear Metal Stents in Treatment of Atherosclerotic Coronary Lesion
雷帕霉素涂層支架與裸金屬支架對冠脈病變的療效
Compare homemade sirolimus-eluting stent to paclitaxel-eluting stent with clinical effect
國產西羅莫司洗脫支架與紫杉醇洗脫支架臨床效果比較研究
Safety and efficacy of sirolimus eluting stent in patients with small renal artery stenotic lesions
小直徑腎動脈狹窄應用西羅莫司洗脫支架的安全性和有效性
Comparison of sirolimus eluting stenting versus bare metal stenting in type 2 diabetic patients with very small coronary artery lesions
合并2型糖尿病的冠狀動脈小血管病變植入雷帕酶素洗脫支架與金屬裸支架療效比較
Effects of sirolimus on recurrence of cancer after liver transplantation
西羅莫司對肝癌肝移植術后腫瘤復發的抑制作用
Effect of Sirolimus on preventing transplant arteriosclerosis in rats
西羅莫司對移植動脈粥樣硬化的預防作用
Advances in the Study of Preventing Coronary Restenosis with Sirolimus Eluting Stent
雷帕霉素涂層支架預防血管內再狹窄的研究進展
Application of Sirolimus-Eluting Stents in Patients with Coronary Artery Disease and Type 2 Diabetes
雷帕霉素洗脫支架在冠心病合并2型糖尿病患者中的應用
